Status:
COMPLETED
Recovery Support for Bladder Cancer Patients and Caregivers
Lead Sponsor:
Northwell Health
Collaborating Sponsors:
Fox Chase Cancer Center
Conditions:
Bladder Cancer
Patient Engagement
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
For patients with certain types of bladder cancer, the removal of the bladder and the construction of an artificial bladder or reservoir are the only treatment options. Both before and after treatment...
Detailed Description
Treatment for certain types of bladder cancer (BC) involves the removal of the bladder and construction of a new voiding system and is physically and psychologically profoundly challenging for patient...
Eligibility Criteria
Inclusion
- (a) male or female patients diagnosed with BC
- (b) undergoing bladder removal surgery and one of the following urinary diversions: 1) ileal conduit, 2) neobladder or 3) Indiana pouch.
- (c) did not need or completed neo-adjuvant chemotherapy,
- (d) able to communicate with ease in English
Exclusion
- (a) the caregiving relationship is temporary (e.g., an out-of-town relative provides temporary support) as stated by both patient and caregiver.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 16 2024
Estimated Enrollment :
174 Patients enrolled
Trial Details
Trial ID
NCT04055311
Start Date
October 1 2018
End Date
December 16 2024
Last Update
October 1 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwell Health
Manhasset, New York, United States, 11030
2
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111